Login / Signup

Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).

Wenxin XuMäneka PuligandlaBrian HalbertNaomi B HaasKeith T FlahertyRobert G UzzoJanice P DutcherRobert S DiPaolaVenkata SabbisettiRupal S Bhatt
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Post-nephrectomy plasma KIM-1 is associated with DFS and OS in RCC, and may be a biomarker for microscopic residual disease.
Keyphrases
  • renal cell carcinoma
  • robot assisted
  • editorial comment
  • clinical trial
  • study protocol
  • phase ii
  • free survival